These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1257 related items for PubMed ID: 19032452

  • 1. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
    Choi GH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Lee WJ, Han KH, Chon CY, Kim BR.
    J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
    [Abstract] [Full Text] [Related]

  • 2. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.
    Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J.
    Cancer; 2000 Aug 01; 89(3):500-7. PubMed ID: 10931448
    [Abstract] [Full Text] [Related]

  • 3. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY.
    J Hepatol; 2007 Nov 01; 47(5):684-90. PubMed ID: 17854945
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Makino Y, Yamanoi A, Kimoto T, El-Assal ON, Kohno H, Nagasue N.
    Am J Gastroenterol; 2000 May 01; 95(5):1294-300. PubMed ID: 10811342
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.
    Surgery; 2007 Mar 01; 141(3):330-9. PubMed ID: 17349844
    [Abstract] [Full Text] [Related]

  • 10. Risk factors of intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Hanazaki K, Matsushita A, Nakagawa K, Misawa R, Amano J.
    Hepatogastroenterology; 2005 Mar 01; 52(62):580-6. PubMed ID: 15816482
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.
    Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J.
    Cancer; 2013 Jan 01; 119(1):126-35. PubMed ID: 22736338
    [Abstract] [Full Text] [Related]

  • 16. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M.
    Ann Surg Oncol; 2008 May 01; 15(5):1375-82. PubMed ID: 18324443
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis.
    Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Kumada H.
    J Gastroenterol Hepatol; 2008 Nov 01; 23(11):1739-46. PubMed ID: 18713301
    [Abstract] [Full Text] [Related]

  • 20. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP.
    Ann Surg; 2009 Apr 01; 249(4):617-23. PubMed ID: 19300227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.